The Centre for Global Development report, titled “Forecasting the Fallout from AMR: Economic Impacts of Antimicrobial Resistance in Humans,” presents a comprehensive analysis of the far-reaching economic and health consequences of antimicrobial resistance (AMR), particularly on low- and lower-middle-income countries. The study estimates that under current trends, AMR could increase global healthcare costs by $159 billion and shrink the global economy by $1.7 trillion by 2050. However, providing high-quality treatment and supporting antibiotic innovation could save $97 billion in health costs and boost the global economy by $990 billion. The report outlines a return on investment of 28:1 by improving AMR treatment and prevention efforts.